Lushang Freda Pharmaceutical Co.,Ltd.’s Net Profit Rose 13.8% in First Half of 2023

Lushang Freda Pharmaceutical Co.,Ltd. (鲁商福瑞达医药股份有限公司) (600223.SH) reported a net profit of 234.5 million yuan in the first half of 2023, up 13.8% year-on-year.

Meanwhile, the company posted 2.5 billion yuan in revenue, down 48.8% year-on-year.

At the end of the reporting period, it had 11.1 billion yuan in total assets and 6.5 billion yuan in total liabilities, with a liability-to-asset ratio of 58.6%.